Alicia Secor's Net Worth

$2.33 Million

Estimate Recalculated Sep 18, 2024 03:19PM EST

Who is Alicia Secor?

Alicia Secor has an estimated net worth of $2.33 Million. This is based on reported shares across multiple companies, which include GW PHARMACEUTICALS PLC, G1 Therapeutics, Inc., ZAFGEN, INC., Orchard Therapeutics plc, JUNIPER PHARMACEUTICALS INC, and SYNAGEVA BIOPHARMA CORP.

SEC CIK

Alicia Secor's CIK is 0001584516

Past Insider Trading and Trends

2021 was Alicia Secor's most active year for acquiring shares with 6 total transactions. Alicia Secor's most active month to acquire stocks was the month of May. 2021 was Alicia Secor's most active year for disposing of shares, totalling 9 transactions. Alicia Secor's most active month to dispose stocks was the month of February. 2015 saw Alicia Secor paying a total of $241,750.00 for 85,000 shares, this is the most they've acquired in one year. In 2018 Alicia Secor cashed out on 571,700 shares for a total of $1,239,978.50, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

GW PHARMACEUTICALS PLC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-10.58K
—
—
0
May 5
Form 4
+21.66%
1.88K
$17.85
-$22,486.60
10.58K
Mar 1
Form 4
—
0
—
—
0
Feb 22
Form 4
+32.54%
2.14K
$9.62
-$13,847.79
8.7K
Jan 4
Form 4
—
0
—
—
0
Jun 4
Form 4
-7.31%
-1.30K
$8.34
-$10,808.64
16.44K
Mar 2
Form 4
-7.97%
-1.54K
$8.53
-$13,102.08
17.74K
Jan 3
Form 4
-4.46%
-900.00
$14.20
-$12,780.00
19.27K
Mar 13
Form 4
+21.58%
3.58K
—
$4.65
20.17K
Jan 3
Form 4
—
0
—
—
0
Mar 1
Form 3
—
0
—
—
0
No matching records found

G1 Therapeutics, Inc. (GTHX) Snapshot price: $7.12

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-30.00K
—
—
0
Sep 18
Form 4
+50.00%
10K
—
—
30K
Jun 13
Form 4
+100.00%
10K
—
—
20K
Jun 15
Form 4
∞
10K
—
—
10K
Jun 23
Form 4
—
0
—
—
0
Jun 17
Form 3
—
0
—
—
0
No matching records found

ZAFGEN, INC. (LRMR) Snapshot price: $8.05

Chief Commercial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Mar 31
Form 4
-100.00%
-1.26K
$25.36
-$836,058.80
0
Scheduled
Sep 17
Form 4
—
0
—
—
0
Feb 27
Form 4
∞
4K
$20.00
$80,000.00
4K
Jun 19
Form 3
—
0
—
—
0
No matching records found

Orchard Therapeutics plc (ORTX) No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jan 24
Form 4
—
0
—
—
0
Jun 14
Form 4
—
0
—
—
0
Jun 7
Form 4
—
0
—
—
0
Jun 16
Form 4
—
0
—
—
0
Jun 17
Form 3
—
0
—
—
0
No matching records found

JUNIPER PHARMACEUTICALS INC No price found

President and CEO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-103.86K
$11.50
-$1,194,332.50
0
Aug 14
Form 4
-2.12%
-1.87K
$8.80
-$16,456.00
86.36K
Mar 3
Form 4
+133.86%
50.5K
—
—
88.22K
Feb 9
Form 4
+20.91%
6.53K
$8.40
-$29,190.00
37.73K
Feb 7
Form 4
+524.00%
26.2K
—
—
31.2K
Mar 3
Form 4
∞
5K
$5.75
$28,750.00
5K
Aug 25
Form 3
—
0
—
—
0
No matching records found